AstraZeneca begins selling a Chinese-developed lung cancer drug in the US
⏮ BeforeSome American patients had to fly to China to buy the drug.
✅ NowAstraZeneca has begun selling the drug in the US.
In short
- AstraZeneca has started selling a Chinese-developed lung cancer drug in the United States.
- Some American patients had previously travelled to China to obtain the drug.
- The source does not give details on price, approval or availability.
Why the Good News Desk likes this one
Some patients had been flying to China to get a treatment that was not sold in the US. Its arrival on the American market means those patients no longer need to make that journey. The source gives no further detail on how widely it is available.
Advertisement
From VnExpress
AstraZeneca has begun selling a Chinese-developed lung cancer drug in the U.S. that some American patients had been flying to China to buy.
Ask this story
More like this
Advertisement